120 related articles for article (PubMed ID: 1642616)
1. Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome.
Hickie I; Lloyd A; Wakefield D
Aust N Z J Psychiatry; 1992 Jun; 26(2):249-56. PubMed ID: 1642616
[TBL] [Abstract][Full Text] [Related]
2. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
Raison CL; Lin JM; Reeves WC
Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.
ter Wolbeek M; van Doornen LJ; Kavelaars A; van de Putte EM; Schedlowski M; Heijnen CJ
Brain Behav Immun; 2007 Nov; 21(8):1063-74. PubMed ID: 17544255
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
[TBL] [Abstract][Full Text] [Related]
5. In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation.
Maes M; Mihaylova I; Leunis JC
Neuro Endocrinol Lett; 2005 Dec; 26(6):745-51. PubMed ID: 16380690
[TBL] [Abstract][Full Text] [Related]
6. An overview of chronic fatigue syndrome.
Krupp LB; Mendelson WB; Friedman R
J Clin Psychiatry; 1991 Oct; 52(10):403-10. PubMed ID: 1938975
[TBL] [Abstract][Full Text] [Related]
7. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression.
Maes M; Mihaylova I; Leunis JC
Neuro Endocrinol Lett; 2007 Dec; 28(6):861-7. PubMed ID: 18063934
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunity in monozygotic twins discordant for chronic fatigue syndrome.
Sabath DE; Barcy S; Koelle DM; Zeh J; Ashton S; Buchwald D
J Infect Dis; 2002 Mar; 185(6):828-32. PubMed ID: 11920301
[TBL] [Abstract][Full Text] [Related]
9. Delayed-type hypersensitivity and chronic fatigue syndrome: the usefulness of assessing T-cell activation by flow cytometry--preliminary study.
Brunet JL; Liaudet AP; Later R; Peyramond D; Cozon GJ
Allerg Immunol (Paris); 2001 Apr; 33(4):166-72. PubMed ID: 11434196
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.
Lloyd A; Hickie I; Wakefield D; Boughton C; Dwyer J
Am J Med; 1990 Nov; 89(5):561-8. PubMed ID: 2146875
[TBL] [Abstract][Full Text] [Related]
11. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
Amsterdam JD; Shults J; Rutherford N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
[TBL] [Abstract][Full Text] [Related]
12. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS.
Maes M; Mihaylova I; Kubera M; Leunis JC
Neuro Endocrinol Lett; 2008 Jun; 29(3):313-9. PubMed ID: 18580855
[TBL] [Abstract][Full Text] [Related]
13. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.
Chapenko S; Krumina A; Kozireva S; Nora Z; Sultanova A; Viksna L; Murovska M
J Clin Virol; 2006 Dec; 37 Suppl 1():S47-51. PubMed ID: 17276369
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of chronic fatigue syndrome].
Uchida A
Nihon Rinsho; 1992 Nov; 50(11):2679-83. PubMed ID: 1287242
[TBL] [Abstract][Full Text] [Related]
15. Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS.
Maes M; Mihaylova I; De Ruyter M
J Affect Disord; 2006 Feb; 90(2-3):141-7. PubMed ID: 16338007
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression.
Lloyd A; Hickie I; Hickie C; Dwyer J; Wakefield D
Clin Exp Immunol; 1992 Jan; 87(1):76-9. PubMed ID: 1733640
[TBL] [Abstract][Full Text] [Related]
17. A psychodynamic view of the chronic fatigue syndrome. The role of object relations in etiology and treatment.
Taerk G; Gnam W
Gen Hosp Psychiatry; 1994 Sep; 16(5):319-25. PubMed ID: 7995502
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of chronic active herpesvirus-6 infection in patients with chronic fatigue syndrome: data acquisition for computer modeling.
Krueger GR; Koch B; Hoffmann A; Rojo J; Brandt ME; Wang G; Buja LM
In Vivo; 2001; 15(6):461-5. PubMed ID: 11887330
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care.
Darbishire L; Ridsdale L; Seed PT
Br J Gen Pract; 2003 Jun; 53(491):441-5. PubMed ID: 12939888
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of the relationship between psychological distress and recurrence of upper respiratory tract infections in chronic fatigue syndrome.
Faulkner S; Smith A
Br J Health Psychol; 2008 Feb; 13(Pt 1):177-86. PubMed ID: 17535488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
